SEVERE ASTHMA
Clinical trials for SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could tame severe asthma in major trial
Disease control Not yet recruitingThis study tests a new drug called frevecitinib (KN-002) for people with severe asthma that is not well controlled by their current inhalers. About 512 adults will receive either the drug or a placebo for 12 weeks to see if it improves lung function and reduces symptoms. The goal…
Matched conditions: SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Kinaset Therapeutics Inc • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
New monthly shot could keep severe asthma patients out of the ER
Disease control Not yet recruitingThis study tests whether starting Tezepelumab, a monthly injection, in the emergency room helps adults with severe asthma recover faster and avoid future attacks. About 100 adults aged 18-55 who use high-dose inhalers will get either Tezepelumab or a placebo alongside standard ca…
Matched conditions: SEVERE ASTHMA
Phase: PHASE4 • Sponsor: University of Alberta • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New asthma drug under Real-World watch in korea
Disease control Not yet recruitingThis study monitors the safety and effectiveness of Tezepelumab (Tezspire) in 210 people with severe asthma in South Korea. Researchers will track side effects and asthma control over 24 weeks during routine treatment. The goal is to ensure the drug works well and is safe in ever…
Matched conditions: SEVERE ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 13, 2026 16:02 UTC